Skip to main content

Want a detailed portfolio tracker?

Vivani Medical (VANI) P/E (2015 - 2026)

Vivani Medical (VANI) P/E from Sep 30, 2015 to Jun 3, 2026. The TTM Vivani Medical (VANI) P/E is -15.98. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Vivani Medical (VANI)

YearP/EChange
2026-15.98+12.71%
2025-14.18+24.84%
2024-11.36+67.40%
2023-6.78+20.04%
2022-5.65-82.62%
2021-32.53+23.46%
2020-26.34-73.00%
2019-97.56+63.46%
2018-59.69-53.79%
2017-129.15+25.05%
2016-103.28-66.55%
2015-308.80N/A

Comparison Vivani Medical (VANI) P/E with competitors

Vivani Medical (VANI) P/E is -15.98.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.10-100.64%
ENLVEnlivex Therapeutics Ltd0.15-100.94%
FGENFibroGen Inc0.24-101.50%
TRAWTraws Pharma Inc0.47-102.96%
FBIOFortress Biotech Inc0.71-104.42%
CHRSCoherus Biosciences Inc0.98-106.12%
ORMPOramed Pharmaceuticals Inc1.47-109.22%
AGENAgenus Inc2.05-112.82%
VIVSVivoSim Labs Inc2.54-115.87%
INVAInnoviva Inc3.19-119.95%
CRMDCorMedix Inc3.65-122.81%
ABEOAbeona Therapeutics Inc4.20-126.31%
VXRTVaxart Inc4.26-126.67%
CVACCureVac N.V.4.45-127.82%
SRPTSarepta Therapeutics Inc4.62-128.94%
GLPGGalapagos NV4.86-130.40%
RIGLRigel Pharmaceuticals4.92-130.78%
ZVRAZevra Therapeutics Inc4.97-131.12%
ABUSArbutus Biopharma Corp5.69-135.63%
CGENCompugen Ltd7.38-146.20%
AUPHAurinia Pharmaceuticals Inc9.25-157.89%
ACADAcadia Pharmaceuticals Inc9.59-160.00%
OMEROmeros Corporation9.88-161.85%
PLXProtalix BioTherapeutics Inc9.91-162.01%
SPROSpero Therapeutics Inc10.73-167.17%
ADMAAdma Biologics Inc11.33-170.90%
SVASinovac Biotech Ltd11.44-171.56%
TBPHTheravance Biopharma Inc11.78-173.69%
HRMYHarmony Biosciences Holdings Inc12.18-176.22%
TGTXTG Therapeutics Inc13.18-182.47%
INCYIncyte Corp13.38-183.74%
SABSSAB Biotherapeutics Inc14.06-187.97%
XOMAXOMA Corp14.95-193.52%
REGNRegeneron Pharmaceuticals Inc14.98-193.74%
PBYIPuma Biotechnology Inc15.05-194.18%
EXELExelixis Inc15.79-198.84%
NAGENiagen Bioscience Inc16.35-202.34%
CPRXCatalyst Pharmaceuticals Inc17.34-208.53%
MDXGMimedx Group Inc17.38-208.73%
ARGXArgen X SE23.07-244.37%
HALOHalozyme Therapeutics Inc23.20-245.18%
XOMAOXOMA Corp25.34-258.59%
VRTXVertex Pharmaceuticals Inc25.66-260.54%
XOMAPXOMA Corp25.67-260.63%
CTMXCytomX Therapeutics Inc25.70-260.80%
ASNDAscendis Pharma A/S26.35-264.91%
RPRXRoyalty Pharma plc - Class A27.50-272.05%
SLNOSoleno Therapeutics Inc29.02-281.56%
LGNDLigand Pharmaceuticals Inc - Class B30.19-288.89%
BMRNBiomarin Pharmaceutical Inc37.51-334.70%
APLSApellis Pharmaceuticals Inc39.02-344.17%
KRYSKrystal Biotech Inc39.70-348.41%
GMABGenmab40.20-351.57%
ONCBeiGene Ltd67.03-519.42%
TECHBio-Techne Corp68.59-529.23%
PHARPharming Group N.V.87.74-649.03%
ALNYAlnylam Pharmaceuticals Inc124.93-881.77%
TLXTelix Pharmaceuticals Ltd139.89-975.36%
CORTCorcept Therapeutics Inc158.39-1091.12%